OptimizeRx shareholders approve 1.95M share increase to equity plan at annual meeting

OptimizeRx Corp

Shareholders approved amendment to 2021 Equity Plan increasing share pool from 2.5M to 4.45M shares (increase of 1.95M).
Equity plan vote: 10,129,247 for, 3,425,566 against, 8,853 abstain, 1,966,973 broker non-votes.
All six director nominees elected; advisory say-on-pay approved with 8,790,190 for votes.
UHY LLP ratified as independent auditor for fiscal 2024 with 13,628,263 votes for, 24,012 against, 1,878,364 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.